Correlations of Plasma Biomarkers and Imaging Characteristics of Cerebral Small Vessel Disease

Qianqian Kong,Xinxin Xie,Ziyue Wang,Yi Zhang,Xirui Zhou,Lingshan Wu,Zhiyuan Yu,Hao Huang,Xiang Luo
DOI: https://doi.org/10.3390/brainsci14030269
IF: 3.333
2024-03-13
Brain Sciences
Abstract:Cerebral small vessel disease (CSVD), which is a group of pathological processes affecting cerebral microvessels, leads to functional loss in the elderly population and mostly presents as cognitive impairment and gait decline. CSVD is diagnosed based on brain imaging biomarkers, but blood biomarkers are of great significance for the early diagnosis and progression prediction of CSVD and have become a research focus because of their noninvasiveness and easy accessibility. Notably, many blood biomarkers have been reported to be associated with CSVD in a relatively large population, particularly serum neurofilament light chain (NfL), which has been regarded as a promising biomarker to track the variation trend in WMH and to predict the further status of white matter hyperintensities (WMH) and lacunar infarcts. And neuro-glio-vascular unit structure and blood–brain barrier function have been proposed as underlying mechanisms of CSVD. The article starts from the neuroimaging markers of CSVD, including recent small subcortical infarcts (RSSI), white matter hyperintensities (WMH), lacunes, cerebral microbleeds (CMB), enlarged perivascular spaces (EPVS), cerebral atrophy, and the combined small vessel disease score, and attempts to systematically review and summarize the research progress regarding the blood biomarkers of CSVD that form the changes in the neuro-glio-vascular unit structure and blood–brain barrier function.
neurosciences
What problem does this paper attempt to address?
The paper primarily explores the relevant plasma biomarkers of Cerebral Small Vessel Disease (CSVD) and their association with the neuroimaging characteristics of CSVD. CSVD is a group of pathological processes affecting the brain's microvasculature, typically leading to functional loss in the elderly, manifesting as cognitive impairment and gait decline. The main objectives of the paper include: 1. **Review of Plasma Biomarkers**: Systematically reviewing and summarizing the research progress on plasma biomarkers related to CSVD, which can reflect changes in the neuro-glial-vascular unit structure and the function of the blood-brain barrier. 2. **Association Analysis**: Investigating the relationship between these plasma biomarkers and the neuroimaging markers of CSVD, such as Recent Small Subcortical Infarcts (RSSI), White Matter Hyperintensities (WMH), lacunes, Cerebral Microbleeds (CMB), Enlarged Perivascular Spaces (EPVS), brain atrophy, etc. 3. **Mechanism Exploration**: Discussing the role of the neuro-glial-vascular unit structure and blood-brain barrier function in the occurrence and development of CSVD. Through a literature search strategy, the authors collected relevant studies and classified and discussed the plasma biomarkers, focusing on those associated with different neuroimaging characteristics. These biomarkers may help in early diagnosis, predicting disease progression, and understanding the pathogenesis of CSVD. For example, Neurofilament Light Chain (NfL) is considered a promising biomarker that can track the trend of white matter hyperintensities and predict its further state. Additionally, the paper discusses other biomarkers related to different CSVD imaging characteristics, such as inflammatory markers, endothelial dysfunction markers, etc. In summary, this paper aims to provide a theoretical basis for further research by systematically reviewing existing studies and summarizing the potential value of plasma biomarkers in the diagnosis and prognostic evaluation of CSVD.